Rachel Ware Miller, MD

Clinical interests

  • Gynecologic Oncology
  • Minimally Invasive Surgery, Including Robotic Assisted Procedures
  • Ovarian Cancer Screening and Treatment
  • Radical Pelvic Surgery

Rachel Ware Miller, MD

Biography

molecular-tumor-board-codirectorsMolecular Tumor Board codirectors, Dr. Rachel Miller and Jill Kolesar, PharmD.

My name is Rachel Ware Miller; I received my medical degree from the University of Kentucky, College of Medicine, Lexington. I then completed a fellowship at the University of Kentucky, Lexington.

I am board certified by the American Board of Obstetrics and Gynecology in Obstetrics and Gynecology and Gynecologic Oncology.

Faculty rank

Associate Professor of Obstetrics and Gynecology

Education

Degree
University of Kentucky, College of Medicine, Lexington

Residency
Dartmouth-Hitchcock Medical Center, Hanover, N.H.

Fellowship
University of Kentucky, Lexington

Certifications or Special training
American Board of Obstetrics and Gynecology
American Board of Obstetrics and Gynecology, Gynecologic Oncology

Gynecologic Oncology

Gynecologic Oncology Clinic

Markey Cancer Center
Whitney-Hendrickson Building
Third Floor, Room 330A
740 Rose St.
Lexington KY 40536-0098

Call 859-323-5553
Call 866-340-4488
Fax 859-323-1602

Directions to Markey Cancer Center - Whitney-Hendrickson Building »


UK HealthCare accepts many forms of insurance. See list of insurers »

 
  1. Lefringhouse JR, Neward E, Ueland FR, Baldwin LA, Miller RW, DeSimone CP, Kryscio RJ, van Nagell JR, Pavlik EJ. Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women. Womens Health (Lond). 2016 Jun;12(3):303-11.
    View in: PubMed
  2. van Nagell JR, Miller RW. Evaluation and Management of Ultrasonographically Detected Ovarian Tumors in Asymptomatic Women. Obstet Gynecol. 2016 May;127(5):848-58.
    View in: PubMed
  3. Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR, Ueland FR. Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index. Gynecol Oncol. 2014 Oct;135(1):8-12.
    View in: PubMed
  4. Goodrich ST, Bristow RE, Santoso JT, Miller RW, Smith A, Zhang Z, Ueland FR. The effect of ovarian imaging on the clinical interpretation of a multivariate index assay. Am J Obstet Gynecol. 2014 Jul;211(1):65.e1-65.e11.
    View in: PubMed
  5. Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR. Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography. Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7.
    View in: PubMed
  6. Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012 Sep; 120(3):612-8. PMID: 22914471.
    View in: PubMed
  7. Miller RW, Ueland FR. Risk of malignancy in sonographically confirmed ovarian tumors. Clin Obstet Gynecol. 2012 Mar; 55(1):52-64. PMID: 22343229.
    View in: PubMed
  8. van Nagell JR, Miller RW, DeSimone CP, Ueland FR, Podzielinski I, Goodrich ST, Elder JW, Huang B, Kryscio RJ, Pavlik EJ. Long-term survival of women with epithelial ovarian cancer detected by ultrasonographic screening. Obstet Gynecol. 2011 Dec; 118(6):1212-21. PMID: 22105249.
    View in: PubMed
  9. Ware Miller R, Smith A, DeSimone CP, Seamon L, Goodrich S, Podzielinski I, Sokoll L, van Nagell JR, Zhang Z, Ueland FR. Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay. Obstet Gynecol. 2011 Jun; 117(6):1298-306. PMID: 21555961.
    View in: PubMed
  10. Miller RW, van Nagell JR. Preoperative evaluation of adnexal masses. Womens Health (Lond Engl). 2011 Jan; 7(1):37-9. PMID: 21175389.
    View in: PubMed